Advertisement
U.S. markets closed

Pfizer Inc. (PFE)

NYSE - Nasdaq Real Time Price. Currency in USD
27.75-0.03 (-0.11%)
At close: 04:00PM EDT
27.76 +0.01 (+0.05%)
After hours: 07:43PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Flag (Bullish)

Flag (Bullish)

Previous Close27.78
Open27.82
Bid27.81 x 3200
Ask27.76 x 3000
Day's Range27.72 - 28.12
52 Week Range25.61 - 42.22
Volume39,793,316
Avg. Volume43,665,659
Market Cap157.135B
Beta (5Y Monthly)0.56
PE Ratio (TTM)75.00
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.68 (6.05%)
Ex-Dividend DateJan 25, 2024
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
63% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for PFE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Pfizer, Inc.
    Technical Assessment: Neutral in the Intermediate-TermWas that a case of quarter-end buying by institutions? Over the last 50 minutes of the trading session on Wednesday, the S&P 500 (SPX) took off like a rocket, surging 30 points and finishing 0.9% higher on the day and at another all-time high. But the biggest winners on the day were small-caps, with the Russell 2000 (IWM) surging 2.2% and the S&P 600 (SML) spiking 2.4%. The IWM is breaking out of a more-than two-year base and closed at its highest level since December 2021.
    Rating
    Fair Value
    Economic Moat
    13 hours agoArgus Research
View more